Natural acquired group B Streptococcus capsular polysaccharide and surface protein antibodies in HIV-infected and HIV-uninfected children

被引:4
作者
Dzanibe, Sonwabile [1 ,2 ]
Adrian, Peter V. [1 ,2 ]
Mlacha, Sheila Z. Kimaro [1 ,2 ]
Madhi, Shabir A. [1 ,2 ,3 ]
机构
[1] Univ Witwatersrand, Natl Res Fdn Vaccine Preventable, Dept Sci & Technol, Johannesburg, South Africa
[2] Univ Witwatersrand, Resp & Meningeal Pathogens Res Unit, MRC, Johannesburg, South Africa
[3] Natl Inst Communicable Dis, Johannesburg, South Africa
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
Group B Streptococcus; Surface proteins; Capsular polysaccharides; HIV; Antibodies; SIGNAL PEPTIDES; DISEASE; VACCINE; ONSET; IMMUNOGENICITY; IDENTIFICATION; COLONIZATION; PNEUMONIAE; PROTECTION; LEVEL;
D O I
10.1016/j.vaccine.2016.09.015
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Group B Streptococcus (GBS) is a major cause of invasive disease in young infants and also in older immunocompromised individuals, including HIV-infected persons. We compared naturally acquired antibody titres to GBS polysaccharide and surface protein antigens in HIV-uninfected and HIV-infected children aged 4-7 years. A multiplex Luminex immunoassay was used to measure IgG concentrations against GBS capsular polysaccharides (CPS) for serotypes la, Ib, III and V; and also extracellular localizing proteins which included cell-wall anchored proteins: Fibrinogen binding surface Antigen (FbsA), GBS Immunogenic Bacterial Adhesin (BibA), Surface immunogenic protein (Sip), gbs0393, gbs1356, gbs1539, gbs0392; and lipoproteins gbt0233, gbs2106 and Foldase PsrA. HIV-infected children (n = 68) had significantly lower IgG GMT compared to HIV-uninfected (n = 77) children against CPS of serotype Ib (p = 0.012) and V (p = 0.0045), and surface proteins Sip (p < 0.001) and gbs2106 (p = 0.0014). IgG GMT against GBS surface proteins: FbsA, gbs1539, gbs1356, gbs0392, gbs0393 and Foldase PsrA were significantly higher in HIV-infected children (p < 0.004). Moreover, amongst HIV infected children, IgG GMT to GBS surface proteins were higher in those with CD4(+) lymphocyte counts <500 cell/mu L compared to those who had CD4(+) lymphocyte count >= 500 cell/mu L with the exception of Sip. The increased susceptibility to invasive GBS disease in HIV-infected individuals could be due to the lower serotype specific capsular antibody and possibly due to lower antibody to some of the GBS proteins such as Sip and gbs2106. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5217 / 5224
页数:8
相关论文
共 46 条
[11]   Association of Streptococcus pneumoniae common protein antigen (CPA) antibodies and pneumococcal nasopharyngeal colonization in HIV-infected and HIV-uninfected African children [J].
Ditse, Z. ;
Adrian, P. V. ;
Kuwanda, L. ;
Madhi, S. A. .
VACCINE, 2013, 31 (40) :4421-4427
[12]   Predicting subcellular localization of proteins based on their N-terminal amino acid sequence [J].
Emanuelsson, O ;
Nielsen, H ;
Brunak, S ;
von Heijne, G .
JOURNAL OF MOLECULAR BIOLOGY, 2000, 300 (04) :1005-1016
[13]   A POPULATION-BASED ASSESSMENT OF INVASIVE DISEASE DUE TO GROUP-B STREPTOCOCCUS IN NONPREGNANT ADULTS [J].
FARLEY, MM ;
HARVEY, RC ;
STULL, T ;
SMITH, JD ;
SCHUCHAT, A ;
WENGER, JD ;
STEPHENS, DS .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (25) :1807-1811
[14]   An automatic method for identifying surface proteins in bacteria: SLEP [J].
Giombini, Emanuela ;
Orsini, Massimiliano ;
Carrabino, Danilo ;
Tramontano, Anna .
BMC BIOINFORMATICS, 2010, 11
[15]  
Heyderman RS, 2016, LANCET INFECT DIS, V3099, P1
[16]   INVASIVE GROUP-B STREPTOCOCCAL DISEASE IN CHILDREN BEYOND EARLY INFANCY [J].
HUSSAIN, SM ;
LUEDTKE, GS ;
BAKER, CJ ;
SCHLIEVERT, PM ;
LEGGIADRO, RJ .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (04) :278-281
[17]   Group B Streptococcus:: global incidence and vaccine development [J].
Johri, Atul Kumar ;
Paoletti, Lawrence C. ;
Glaser, Philippe ;
Dua, Meenakshi ;
Sharma, Puja Kumari ;
Grandi, Guido ;
Rappuoli, Rino .
NATURE REVIEWS MICROBIOLOGY, 2006, 4 (12) :932-942
[18]   Prediction of lipoprotein signal peptides in Gram-negative bacteria [J].
Juncker, AS ;
Willenbrock, H ;
Von Heijne, G ;
Brunak, S ;
Nielsen, H ;
Krogh, A .
PROTEIN SCIENCE, 2003, 12 (08) :1652-1662
[19]   Safety and immunogenicity of a tetravalent group B streptococcal polysaccharide vaccine in healthy adults [J].
Kotloff, KL ;
Fattom, A ;
Basham, L ;
Hawwari, A ;
Harkonen, S ;
Edelman, R .
VACCINE, 1996, 14 (05) :446-450
[20]   Rapid detection of the "highly virulent" group B streptococcus ST-17 clone [J].
Lamy, Marie-Cecile ;
Dramsi, Shaynoor ;
Billoet, Annick ;
Reglier-Poupet, Helene ;
Tazi, Asmaa ;
Raymond, Josette ;
Guerin, Francois ;
Couve, Elisabeth ;
Kunst, Frank ;
Glaser, Philippe ;
Trieu-Cuot, Patrick ;
Poyart, Claire .
MICROBES AND INFECTION, 2006, 8 (07) :1714-1722